お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1006113

家禽用ワクチンの世界市場:病気の種類別、技術別、剤形別の予測(2026年まで)- COVID-19の累積的影響

Poultry Vaccine Market Research Report by Disease Type, by Technology, by Dosage Form, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.74円
家禽用ワクチンの世界市場:病気の種類別、技術別、剤形別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の家禽用ワクチンの市場規模は、2020年の16億6,499万米ドルから、2025年末までに23億1,768万米ドルに拡大すると予想されています。

COVID-19は、ほぼすべての業界に影響を与えた未曾有の世界の公衆衛生上の緊急事態であるため、予測期間中に業界の成長に長期的な影響を与えると予測されています。当レポートでは、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げ消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19の影響について考察しています。

当レポートは、世界の家禽用ワクチン市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、病気の種類・技術・剤形・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションとカバレッジ
  • 調査期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査設計
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画を作成する
    • 実行:調査を実施する
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査の成果

第3章 エグゼクティブサマリー

  • 市場展望
  • 剤形別市場の展望
  • 病気の種類別市場の展望
  • 技術別市場の展望
  • 地域別市場の展望
  • 競合他社の見通し

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターのファイブフォース分析

第6章 病気の種類別市場

  • 伝染性気管支炎
  • マレック病
  • ニューキャッスル病

第7章 技術別市場

  • 不活化
  • 弱毒生ワクチン
  • 組換え
  • トキソイド

第8章 剤形別市場

  • ダクト
  • フリーズドライワクチン
  • 液体

第9章 南北アメリカ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域市場

  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 契約、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第13章 企業プロファイル

  • Anicon GmbH
  • Bayer
  • Biovac
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • CAVAC
  • Ceva Sante Animale
  • ChengDu Tecbond
  • China Animal Husbandry
  • Dechra Pharmaceuticals PLC
  • DHN
  • Elanco
  • Harbin Veterinary Research Institute
  • Hester Biosciences Limited
  • HIPRA
  • Indovax
  • Merck & Co., Inc.
  • MSD & Co. Inc.
  • Phibro Animal Health Corporation
  • Proteon Pharmaceuticals
  • Ringpu Biology
  • Venkys India
  • Venky's Limited
  • Virbac
  • Zoetis Inc.

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
  • 連絡先の詳細
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL POULTRY VACCINE MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL POULTRY VACCINE MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL POULTRY VACCINE MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2026
  • FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (%)
  • FIGURE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2026
  • FIGURE 20. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, 2018-2026 (USD MILLION)
  • FIGURE 27. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (%)
  • FIGURE 29. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2020 VS 2026 (USD MILLION)
  • FIGURE 30. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2026
  • FIGURE 31. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. BRAZIL POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. CANADA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. MEXICO POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. UNITED STATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. FLORIDA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. ILLINOIS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. NEW YORK POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. OHIO POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. TEXAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. INDIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. INDONESIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. JAPAN POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. MALAYSIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. THAILAND POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GERMANY POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. ITALY POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. QATAR POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. RUSSIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SPAIN POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GLOBAL POULTRY VACCINE MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL POULTRY VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL POULTRY VACCINE MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL POULTRY VACCINE MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL POULTRY VACCINE MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY DUCT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GLOBAL POULTRY VACCINE MARKET: SCORES
  • TABLE 123. GLOBAL POULTRY VACCINE MARKET: BUSINESS STRATEGY
  • TABLE 124. GLOBAL POULTRY VACCINE MARKET: PRODUCT SATISFACTION
  • TABLE 125. GLOBAL POULTRY VACCINE MARKET: RANKING
  • TABLE 126. GLOBAL POULTRY VACCINE MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 127. GLOBAL POULTRY VACCINE MARKET: SHARE, BY COMPANY, 2020
  • TABLE 128. GLOBAL POULTRY VACCINE MARKET: MERGER & ACQUISITION
  • TABLE 129. GLOBAL POULTRY VACCINE MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 130. GLOBAL POULTRY VACCINE MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 131. GLOBAL POULTRY VACCINE MARKET: INVESTMENT & FUNDING
  • TABLE 132. GLOBAL POULTRY VACCINE MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 133. GLOBAL POULTRY VACCINE MARKET: LICENSE & PRICING
  • TABLE 134. GLOBAL POULTRY VACCINE MARKET: CONTACT DETAILS
目次
Product Code: MRR-0375F3EA9C42

The Global Poultry Vaccine Market size was estimated at USD 1,664.99 Million in 2020 and expected to reach USD 1,787.18 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.67% to reach USD 2,595.08 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Poultry Vaccine to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease Type, the Poultry Vaccine Market was studied across Infectious Bronchitis, Marek's Disease, and New Castle Disease.

Based on Technology, the Poultry Vaccine Market was studied across Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.

Based on Dosage Form, the Poultry Vaccine Market was studied across Duct, Freeze Dried Vaccines, and Liquid.

Based on Geography, the Poultry Vaccine Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Poultry Vaccine Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Poultry Vaccine Market, including Anicon GmbH, Bayer, Biovac, Biovet Private Limited, Boehringer Ingelheim International GmbH, CAVAC, Ceva Sante Animale, ChengDu Tecbond, China Animal Husbandry, Dechra Pharmaceuticals PLC, DHN, Elanco, Harbin Veterinary Research Institute, Hester Biosciences Limited, HIPRA, Indovax, Merck & Co., Inc., MSD & Co. Inc., Phibro Animal Health Corporation, Proteon Pharmaceuticals, Ringpu Biology, Venkys India, Venky's Limited, Virbac, and Zoetis Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Poultry Vaccine Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Poultry Vaccine Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Poultry Vaccine Market?
  • 4. What is the competitive strategic window for opportunities in the Global Poultry Vaccine Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Poultry Vaccine Market?
  • 6. What is the market share of the leading vendors in the Global Poultry Vaccine Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Poultry Vaccine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Dosage Form Outlook
  • 3.4. Disease Type Outlook
  • 3.5. Technology Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of animal diseases
      • 5.1.1.2. Surge in awareness on animal vaccination globally
      • 5.1.1.3. Growing need to increase poultry population with demand for animal protein worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for vaccine manufacturing
      • 5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory approval and compliance concerns
      • 5.1.4.2. High cost of veterinary testing and services
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Poultry Vaccine Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Infectious Bronchitis
  • 6.3. Marek's Disease
  • 6.4. New Castle Disease

7. Poultry Vaccine Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant
  • 7.5. Toxoid

8. Poultry Vaccine Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Duct
  • 8.3. Freeze Dried Vaccines
  • 8.4. Liquid

9. Americas Poultry Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Poultry Vaccine Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Poultry Vaccine Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Anicon GmbH
  • 13.2. Bayer
  • 13.3. Biovac
  • 13.4. Biovet Private Limited
  • 13.5. Boehringer Ingelheim International GmbH
  • 13.6. CAVAC
  • 13.7. Ceva Sante Animale
  • 13.8. ChengDu Tecbond
  • 13.9. China Animal Husbandry
  • 13.10. Dechra Pharmaceuticals PLC
  • 13.11. DHN
  • 13.12. Elanco
  • 13.13. Harbin Veterinary Research Institute
  • 13.14. Hester Biosciences Limited
  • 13.15. HIPRA
  • 13.16. Indovax
  • 13.17. Merck & Co., Inc.
  • 13.18. MSD & Co. Inc.
  • 13.19. Phibro Animal Health Corporation
  • 13.20. Proteon Pharmaceuticals
  • 13.21. Ringpu Biology
  • 13.22. Venkys India
  • 13.23. Venky's Limited
  • 13.24. Virbac
  • 13.25. Zoetis Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.